Cargando…
Primary pulmonary lymphoma in Peru
OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enferm...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310327/ https://www.ncbi.nlm.nih.gov/pubmed/37396099 http://dx.doi.org/10.3332/ecancer.2023.1559 |
_version_ | 1785066515167444992 |
---|---|
author | Requena, Elily Dianet Apumayta Ocrospoma, Danery Valdez Ruiz, Jhonatanael Salvador De la Guerra Pancorvo, Alberto Kajatt, Edgar Amorin |
author_facet | Requena, Elily Dianet Apumayta Ocrospoma, Danery Valdez Ruiz, Jhonatanael Salvador De la Guerra Pancorvo, Alberto Kajatt, Edgar Amorin |
author_sort | Requena, Elily Dianet Apumayta |
collection | PubMed |
description | OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enfermedades Neoplásicas in Lima, Perú. RESULTS: 73.9% of patients were male. Cough (78.3%) and weight loss (56.5%) were the most frequent clinical features. Dyspnoea and elevated values of DHL and B2 microglobulin were frequently altered in advanced stages. Diffuse large B cell lymphoma (DLBCL) represented 47.8% of the cases and the most common radiologic alterations were a mass (60%) and consolidation with air bronchogram (60%). The most utilised treatment was chemotherapy alone (60%). Three patients received only surgery. Median survival was 30 months. Five overall survival was 45%, and up to 60% in the case of mucosa-associated lymphoid tissue lymphoma. CONCLUSION: PPL is infrequent. Clinical features are unspecific and the principal finding is a mass, nodule or consolidation with air bronchogram. Definitive diagnosis needs biopsy and immunohistochemistry. There is no standard treatment, it depends on histology type and stage. |
format | Online Article Text |
id | pubmed-10310327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-103103272023-06-30 Primary pulmonary lymphoma in Peru Requena, Elily Dianet Apumayta Ocrospoma, Danery Valdez Ruiz, Jhonatanael Salvador De la Guerra Pancorvo, Alberto Kajatt, Edgar Amorin Ecancermedicalscience Research OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enfermedades Neoplásicas in Lima, Perú. RESULTS: 73.9% of patients were male. Cough (78.3%) and weight loss (56.5%) were the most frequent clinical features. Dyspnoea and elevated values of DHL and B2 microglobulin were frequently altered in advanced stages. Diffuse large B cell lymphoma (DLBCL) represented 47.8% of the cases and the most common radiologic alterations were a mass (60%) and consolidation with air bronchogram (60%). The most utilised treatment was chemotherapy alone (60%). Three patients received only surgery. Median survival was 30 months. Five overall survival was 45%, and up to 60% in the case of mucosa-associated lymphoid tissue lymphoma. CONCLUSION: PPL is infrequent. Clinical features are unspecific and the principal finding is a mass, nodule or consolidation with air bronchogram. Definitive diagnosis needs biopsy and immunohistochemistry. There is no standard treatment, it depends on histology type and stage. Cancer Intelligence 2023-06-15 /pmc/articles/PMC10310327/ /pubmed/37396099 http://dx.doi.org/10.3332/ecancer.2023.1559 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Requena, Elily Dianet Apumayta Ocrospoma, Danery Valdez Ruiz, Jhonatanael Salvador De la Guerra Pancorvo, Alberto Kajatt, Edgar Amorin Primary pulmonary lymphoma in Peru |
title | Primary pulmonary lymphoma in Peru |
title_full | Primary pulmonary lymphoma in Peru |
title_fullStr | Primary pulmonary lymphoma in Peru |
title_full_unstemmed | Primary pulmonary lymphoma in Peru |
title_short | Primary pulmonary lymphoma in Peru |
title_sort | primary pulmonary lymphoma in peru |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310327/ https://www.ncbi.nlm.nih.gov/pubmed/37396099 http://dx.doi.org/10.3332/ecancer.2023.1559 |
work_keys_str_mv | AT requenaelilydianetapumayta primarypulmonarylymphomainperu AT ocrospomadaneryvaldez primarypulmonarylymphomainperu AT ruizjhonatanaelsalvador primarypulmonarylymphomainperu AT delaguerrapancorvoalberto primarypulmonarylymphomainperu AT kajattedgaramorin primarypulmonarylymphomainperu |